article thumbnail

Design Therapeutics Finds $45M

socalTECH

San Diego-based Design Therapeutics , which is developing therapies for patients with serious degenerative disorders caused by nucleotide repeat expansions, has raised $45M in a Series A financing round. The round was led by SR One, and also included Cormorant Asset Management, Quan Capital and WestRiver Group. and Aseem Ansari, Ph.D.

Design 113
article thumbnail

Entos Finds $53M For Drug Design Platform

socalTECH

San Diego-based Entos, a developer of artificial intelligence and automated synthetic development technology for designing small-molecule therapeutics, has raised $53M in a Series A funding. The funding was led by Coatue, and also included Catalio Capital Management, OrbiMed, Sequoia CApital, Nexus Ventures, and Freeflow.

Design 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Design Therapeutics Sets IPO Offering Range

socalTECH

Carlsbad-based Design Therapeutics, a company developing treatments for serious degenerative disorders, has set an expected IPO offering range of between $18.00 The company is venture backed by SR One, Quan Capital, Cormorant Asset Management, and WestRiver Group. and $20.00 per share, the company said in a filing this week.

Design 113
article thumbnail

Design Therapeutics Picks Up $125M For Small Molecules

socalTECH

San Diego-based Design Therapeutics, a biotech company which is developing small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions, said it has raised $125M in its Series B funding round. Wellington Management, Avoro Capital Advisors, Vivo Capital, and others.

Design 113
article thumbnail

Beauty By Design Raises $2.2M

socalTECH

Los Angeles-based Beauty By Design , a startup offering up "hyper-personalized" beauty products based on a customer's skin, has raised $2.2M David Weissman is CEO and Co-founder of Beauty By Design. in a seed funding round. READ MORE>>.

Design 160
article thumbnail

Diversis Capital Raises $675M Fund

socalTECH

Los Angeles-based private equity investor Diversis Capital Management said this morning that it has raised a new, $675M fund. The company said its new fund, Diversis Capital Partners II, exceeded its target of $500M. The company said it reached the $675M in commitments just three months after its formal launch.

Capital 113
article thumbnail

Qulab Applies Artificial Intelligence To Drug Design

socalTECH

Los Angeles-based Qulab , a biopharmaceuticals startup developing artifical intelligence software aimed at small molecule drug design, said on Wednesday that it has launched its first product, Quleap.